Casodex 50mg Tablet

    Casodex 50mg Tablet

    S4
    PDF Leaflet Revision Date: 17 February 2017

    API: Bicalutamide | Company: Astrazeneca

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of advanced prostate cancer.

    Dosage (summary)

    1 tablet (50 mg) once daily.

    Special Populations

    • Renal impairment
    • Hepatic impairment

    Pregnancy & Breastfeeding

    Contraindicated in females, pregnant or nursing women.

    Key Drug Interactions

    • CYP 3A4 inhibitors
    • Warfarin

    Contraindications

    • Females
    • Children
    • Hypersensitivity to bicalutamide

    Common side effects

    • Breast tenderness
    • Gynaecomastia
    • Dizziness
    • Hot flush
    • Nausea

    Counselling Points

    • Monitor liver function
    • Caution with driving if somnolence occurs
    • Monitor blood glucose with LHRH agonists

    Serious warnings

    • Severe hepatic changes
    • Anti-androgen withdrawal syndrome
    Important Disclaimer

    The Casodex 50mg Tablet professional information leaflet below is the property of Astrazeneca and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn